Canocapavir

N/A

Report date: 2025/06/12 17:08:50
NME

Base Information

Drug NameCanocapavir
Drug Alias Name卡农克韦ZM-H1505RCB-01CB-001CB-HBV-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein inhibitors
TargetsCapsid protein
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesHong KongMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Zhimeng Biopharma Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Zhimeng Biopharma Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A